Anti-PLA2R antibody in a secondary cause of membranous nephropathy

Nephrology (Carlton). 2018 Jan;23(1):94-95. doi: 10.1111/nep.12997.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Antiviral Agents / therapeutic use
  • Autoantibodies / blood
  • Autoantibodies / immunology*
  • Biomarkers / blood
  • Glomerulonephritis, Membranous / blood
  • Glomerulonephritis, Membranous / diagnosis
  • Glomerulonephritis, Membranous / drug therapy
  • Glomerulonephritis, Membranous / immunology*
  • Hepatitis B / blood
  • Hepatitis B / diagnosis
  • Hepatitis B / drug therapy
  • Hepatitis B / immunology*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Immunohistochemistry
  • Kidney Glomerulus / immunology*
  • Kidney Glomerulus / pathology
  • Male
  • Receptors, Phospholipase A2 / immunology*
  • Treatment Outcome

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Antiviral Agents
  • Autoantibodies
  • Biomarkers
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Receptors, Phospholipase A2